Monographie - Amsacrine - Stabilis 4.0

Ultimo aggiornamento :
08/05/2024

Farmaco contro il cancro

Amsacrine

Iniezione

Stabilità in soluzione

Stabilità in miscela

Fattori che influenzano la stabilità

Compatibilità

Metodo di iniezione

Bibliografia

Pdf

Struttura chimica

Nome commerciale

Nome commerciale

Trade names are indicative and excipients composition can be different depending on the country and manufacturers

Amekrin	Danimarca, Finlandia, Norvegia, Svezia
Amsa PD	Canada
Amsalyo	Francia
Amsidine	Australia, Belgio, Italia, Paesi Bassi
Amsidyl	Germania, Svizzera

Bibliografia

Iniezione

Bibliografia : Amsacrine

	Tipo	Pubblicazione
182	Rivista	Trissel LA, Gilbert DL, Martinez JF. Compatibility of granisetron hydrochloride with selected drugs during simulated Y-site administration. Am J Health-Syst Pharm 1997 ; 54: 56-60.
253	Rivista	Trissel LA, Chandler SW, Folstad JT. Visual compatibility of amsacrine with selected drugs during simulated Y-site injection. Am J Hosp Pharm 1990 ; 47: 2525-2528.
334	Rivista	Trissel LA, Tramonte SM, Grilley BJ. Visual compatibility of ondansetron hydrochloride with selected drugs during simulated Y-site injection. Am J Hosp Pharm 1991 ; 48: 988-992.
335	Rivista	Trissel LA, Bready BB, Kwan JW, Santiago NM. Visual compatibility of sargramostim with selected antineoplasic agents, anti-infectives, or other drugs during simulated Y-site injection. Am J Hosp Pharm 1992 ; 49: 402-406.
492	Rivista	Trissel LA, Parks NPT, Santiago NM. Visual compatibility of fludarabine phosphate with antineoplastic drugs, anti-infectives, and other selected drugs during simulated Y-site injection. Am J Hosp Pharm 1991 ; 48: 2186-2189.
829	Rivista	Cartwright-Shamoon JM, McElnay JC, D'Arcy PF. Examination of sorption and photodegradation of amsacrine during storage in intravenous burette administration sets. Int J Pharm 1988 ; 42: 41-46.
3523	Laboratorio	Ceftriaxone (Rocephin®) - Summary of Product Characteristics. Roche 2018
3576	Laboratorio	Amsacrine (Amsalyo®) - Résumé des caractéristiques du produit Prostrakan 2012
3595	Laboratorio	Aciclovir - Summary of Product Characteristics Hospira 2009
3745	Rivista	Kuenhle C, Moore Sodium chloride residue provides potential for drug incompatibiities. Am J Hosp Pharm 1979 ; 36: 881.

Mentions Légales